In-silico and in-vitro analysis of novel substituted benzimidazolyl derivatives for antimycobacterial potentials targeting enoyl acyl carrier protein reductase (InhA)
Abstract Background The emergence of mutated drug-resistant strains of Mycobacterium tuberculosis has reinvigorated the development of effective chemotherapy for MDR-TB (multidrug-resistant resistance tuberculosis). Enoyl acyl carrier protein reductase (InhA) involved in the mycobacterial fatty acid...
Saved in:
Main Authors: | Umaa Kuppuswamy (Author), Ravi Kumar Rajan (Author), Arvinth Kumar (Author), Muthiah Ramanathan (Author) |
---|---|
Format: | Book |
Published: |
SpringerOpen,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of Novel Inhibitor of Enoyl-Acyl Carrier Protein Reductase (InhA) Enzyme in <i>Mycobacterium tuberculosis</i> from Plant-Derived Metabolites: An In Silico Study
by: Kratika Singh, et al.
Published: (2022) -
Design, Synthesis and Molecular Docking of Novel Acetophenone-1,2,3-Triazoles Containing Compounds as Potent Enoyl-Acyl Carrier Protein Reductase (InhA) Inhibitors
by: Fawzia Faleh Albelwi, et al.
Published: (2022) -
Docking-Based Virtual Screening and Molecular Dynamics Simulations of Quercetin Analogs as Enoyl-Acyl Carrier Protein Reductase (InhA) Inhibitors of <i>Mycobacterium tuberculosis</i>
by: Dian Ayu Eka Pitaloka, et al.
Published: (2021) -
Computational quest to inhibit enoyl-acyl carrier protein reductase (InhA) enzyme in Mycobacterium tuberculosis from Lannea coromandelica (Houtt.) Merr. metabolite via molecular docking and dynamics
by: Muhammad Askar
Published: (2024) -
In silico study of phytochemicals contained in Brucea javanica in inhibiting the InhA enzyme as antituberculosis
by: Melanny I. Sulistyowaty, et al.
Published: (2023)